Inhibition of androgen receptor transactivation function by adenovirus type 12 E1A undermines prostate cancer cell survival-Reference-Cited by-同舟云学术

Inhibition of androgen receptor transactivation function by adenovirus type 12 E1A undermines prostate cancer cell survival

Published:2018-07-15 Issue:15 Volume:78 Page:1140-1156
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Li Dawei¹²,Tian Guimei²,Wang Jia²³,Zhao Lisa Y.²,Co Olivia²,Underill Zoe C.²,Mymryk Joe S.⁴,Claessens Frank⁵,Dehm Scott M.⁶,Daaka Yehia²,Liao Daiqing²^ORCID

Affiliation:

1. Department of UrologyQilu Hospital of Shandong UniversityJinanP. R. China

2. Department of Anatomy and Cell BiologyUF Health Cancer Center and UF Genetics InstituteUniversity of Florida College of MedicineGainesvilleFlorida

3. Affiliated Dongzhimen HospitalBeijing University of Chinese MedicineBeijingP. R. China

4. Department of Microbiology and ImmunologyLondon Regional Cancer CentreThe University of Western OntarioOntarioCanada

5. Laboratory of Molecular EndocrinologyDepartment of Cellular and Molecular MedicineKU LeuvenLeuvenBelgium

6. Masonic Cancer CenterUniversity of MinnesotaMinneapolisMinnesota

Funder

KU Leuven

National Natural Science Foundation of China

National Cancer Institute

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.23689

Reference67 articles.

1. Cancer statistics, 2013

2. Androgen receptor coregulators: Recruitment via the coactivator binding groove

3. A Hierarchical Network of Transcription Factors Governs Androgen Receptor-Dependent Prostate Cancer Growth

4. Intrinsic disorder in the androgen receptor: identification, characterisation and drugability

5. CREB-binding protein in androgen receptor-mediated signaling

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncolytic Adenoviruses Armed with Co-Stimulatory Molecules for Cancer Treatment;Cancers;2023-03-23

2. Prostate Microbiota and Prostate Cancer: A New Trend in Treatment;Frontiers in Oncology;2021-12-10

3. MYB interacts with androgen receptor, sustains its ligand-independent activation and promotes castration resistance in prostate cancer;British Journal of Cancer;2021-11-26

4. CBP/p300: Critical Co-Activators for Nuclear Steroid Hormone Receptors and Emerging Therapeutic Targets in Prostate and Breast Cancers;Cancers;2021-06-08

5. Androgen receptor variant-driven prostate cancer II: advances in laboratory investigations;Prostate Cancer and Prostatic Diseases;2020-03-05